Table 3.
RDW | MCV | MCHC | Retic | AGLT | GLT | EMA | ||
---|---|---|---|---|---|---|---|---|
Omin | r | 0.033 | −0.236 | 0.308 | 0.266 | −0.658 | −0.545 | −0.589 |
P | 0.72 | 0.008 | 0.0005 | 0.003 | <0.0001 | <0.0001 | <0.0001 | |
Eimax | r | −0.210 | 0.247 | −0.167 | −0.091 | 0.316 | 0.298 | 0.419 |
P | 0.02 | 0.006 | 0.06 | 0.31 | 0.0004 | 0.0008 | <0.0001 | |
Ohyper | r | 0.075 | 0.160 | −0.585 | 0.014 | 0.052 | 0.052 | 0.205 |
P | 0.40 | 0.08 | <0.0001 | 0.875 | 0.57 | 0.57 | 0.022 | |
AUC | r | −0.095 | 0.416 | −0.506 | −0.262 | 0.554 | 0.542 | 0.648 |
P | 0.30 | <0.0001 | <0.0001 | 0.003 | <0.0001 | <0.0001 | <0.0001 |
Spearman' rho correlation analysis was performed in 124 patients for whom all the considered parameters were available.
r, correlation coefficient; P, p-values; GLT, standard glycerol lysis test; AGLT, acidified glycerol lysis test; EMA, eosin-5-maleimide. Highly significant correlations are reported in bold.